Mark Alan Goldberg, Director at Blueprint Medicines Corp (BPMC), bought 5,000 shares at $59.98 ($300K) on 2022-03-03, disclosed to the SEC on 2022-03-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BPMC | SELL | 2020-12-15 | $627K | — | Filing → |
| BPMC | SELL | 2020-12-03 | $600K | — | Filing → |
| BPMC | SELL | 2020-10-21 | $573K | — | Filing → |